MediWound to Present at Upcoming Investor Conferences

Rhea-AI Summary

MediWound (Nasdaq: MDWD) said its management will present at two upcoming investor conferences: Oppenheimer 36th Annual Healthcare Life Sciences on Feb 26, 2026 at 10:40 a.m. ET (virtual), and TD Cowen 46th Annual Health Care on Mar 2, 2026 at 1:10 p.m. ET in Boston.

Webcasts and replays will be available via each conference website and through the Events & Presentations section of MediWound’s Investor Relations site.

MediWound to Present at Upcoming Investor Conferences

YAVNE, Israel, February 17, 2026 -- MediWound Ltd. (Nasdaq: MDWD), a global leader in next-generation enzymatic therapeutics for tissue repair, today announced that its management team will present at the following upcoming investor conferences:

Oppenheimer 36th Annual Healthcare Life Sciences Conference

Date: Thursday, February 26, 2026

Time: 10:40 a.m. ET

Location: Virtual

Webcast: Available via conference website

TD Cowen 46th Annual Health Care Conference

Date: Monday, March 2, 2026

Time: 1:10 p.m. ET

Location: Boston Marriott Copley Place, Boston, MA

Webcast: Available via conference website

A live webcast and replay of each presentation will be accessible through the Events & Presentations section of the Investor Relations area of MediWound’s website.

About MediWound

MediWound Ltd. (Nasdaq: MDWD) is a global biotechnology company pioneering enzymatic, non-surgical therapies for tissue repair. The company’s FDA-approved biologic, NexoBrid^®, is indicated for the enzymatic removal of eschar in thermal burns and is marketed in the United States, European Union, Japan, and additional international markets. MediWound’s late-stage pipeline product, EscharEx^®, is an investigational therapy for the debridement of chronic wounds, with potential to become a new standard of care in wound management.

For more information, visit www.mediwound.com and follow us on LinkedIn and X (formerly Twitter).

MediWound Contacts:
Hani Luxenburg         Chief Financial Officer MediWound Ltd. ir@mediwound.com		Daniel Ferry Managing Director LifeSci Advisors, LLC daniel@lifesciadvisors.com

FAQ

When will MediWound (MDWD) present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference?

MediWound will present on Thursday, February 26, 2026 at 10:40 a.m. ET. According to MediWound, the session is virtual and a live webcast will be available via the conference website and the company's Investor Relations Events & Presentations section.

When and where is MediWound (MDWD) presenting at the TD Cowen 46th Annual Health Care Conference?

MediWound is scheduled for Monday, March 2, 2026 at 1:10 p.m. ET at the Boston Marriott Copley Place. According to MediWound, the presentation will also offer a webcast accessible on the conference website and the company's IR Events & Presentations page.

How can investors watch MediWound (MDWD) presentations and replays from these conferences?

Investors can watch live webcasts and replays via the respective conference websites and MediWound's Investor Relations Events & Presentations section. According to MediWound, each presentation will have a live webcast and a replay available for later viewing.

Will MediWound (MDWD) provide financial updates during the February–March 2026 conference presentations?

The company announced presentation dates and webcast details but did not specify financial disclosures. According to MediWound, investors should view the presentations via the webcast for any management commentary or updates offered during the sessions.

Where can I find archived replays of MediWound (MDWD) investor conference presentations after the events?

Archived replays will be posted in MediWound's Investor Relations Events & Presentations section. According to MediWound, both the Oppenheimer and TD Cowen presentation webcasts and replays will be accessible through the company's IR website.